Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Tilray Q4 Results Top Estimates on Red-Hot International Demand

Published 02/17/2021, 04:27 PM
Updated 02/17/2021, 04:38 PM
© Reuters
ACB
-
CGC
-
APHA
-
TLRY
-

By Yasin Ebrahim

Investing.com - Tilray jumped in after-hours trade Wednesday after the marijuana producer reported fourth-quarter results that markedly beat expectations on strong demand from abroad.  

Tilray (NASDAQ:TLRY) jumped more than 14% in after-hours trade.

The company reported a Q4 loss of 2 cents per share on revenue of $56.56 million, much improved from the $2.14 loss per share and revenue of $46.9 million seen last year. That was also ahead of analysts consensus forecasts for a loss of 14 cents a share on revenue of $56.0 million.  

The beat on the top and bottom lines were led by its cannabis business, with sales rising 46% to $41.2 million, mainly driven by the acceleration of international medical sales, up 191%, and Canadian adult-use sales, up 49%.

"Canadian medical sales grew 26% and there were no bulk sales to other license producers. Hemp segment revenue decreased 18% to $15.3 million (C$20.5 million) primarily due to a shift to private label product with a large customer and the impact of COVID-related changes to consumer shopping patterns," the company said.

Total cannabis kilogram equivalents sold decreased 54% to 6,901 kilograms from 15,039 kilograms in the prior year’s fourth quarter, but the average cost per gram sold increased 37% to $3.24. 

The surge in Tilray post-market close lifted other cannabis stocks higher. Aphria (NASDAQ:APHA), Canopy Growth Corp (NASDAQ:CGC) and Aurora Cannabis Inc (NYSE:ACB) were all sharply higher.

Cannabis stocks have been on a wild ride of late, going on a Reddit-fueled rally earlier this month, before giving back some gains. The stronger quarterly results from cannabis producers of late, however, will likely add further conviction for Redditors to hold, or "diamond hands," the cohort of cannabis stocks.       

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.